Cargando…

Microvascular benefits of hypertension and glucose control in type 2 diabetes

Detalles Bibliográficos
Autor principal:	Van Rensburg, BWJ
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Clinics Cardive Publishing 2008
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3971765/ https://www.ncbi.nlm.nih.gov/pubmed/18776957

Ejemplares similares

Diabetic Microvascular Complications
por: Migdalis, I., et al.
Publicado: (2018)

Impact of White-Coat Hypertension on Microvascular Complications in Type 2 Diabetes
por: Kramer, Caroline K., et al.
Publicado: (2008)

Role of Hyperbaric Oxygen Therapy on Microvascular Diabetic Complications and Metabolic Profile among Patients with Type 2 Diabetes Mellitus
por: Al-Rawahi, Abdulhakeem
Publicado: (2020)

Impact of Specific Glucose-Control Strategies on Microvascular and Macrovascular Outcomes in 58,000 Adults With Type 2 Diabetes
por: Neugebauer, Romain, et al.
Publicado: (2013)

How can we reach the target of glucose control in type 1 diabetes?
por: Bloomgarden, Zachary
Publicado: (2023)

Prospects of stem cell therapy for diabetic microvascular complications
por: Naruse, Keiko
Publicado: (2022)

Association of triglyceride glucose index and triglyceride HDL ratio with glucose levels, microvascular and macrovascular complications in Diabetes Mellitus Type-2
por: Jabeen, Wajiha Mah, et al.
Publicado: (2023)

Navigating the Seas of Glycemic Control: The Role of Continuous Glucose Monitoring in Type 1 Diabetes Mellitus
por: Moon, Jun Sung
Publicado: (2023)

Translating diabetes research from multiple directions – microvascular to psychosocial
por: Olson, Darin E.
Publicado: (2017)

Effect of Glucose Variability on the Long-Term Risk of Microvascular Complications in Type 1 Diabetes
por: Kilpatrick, Eric S., et al.
Publicado: (2009)

Self-Monitoring of Blood Glucose in Patients with Insulin-Treated Type 2 Diabetes Mellitus
por: Kim, Kyung-Soo
Publicado: (2018)

Rapamycin treatment benefits glucose metabolism in mouse models of type 2 diabetes
por: Reifsnyder, Peter C., et al.
Publicado: (2016)

Glucose control in critically ill diabetic: Not so sweet
por: Todi, S. K.
Publicado: (2016)

Benefits from the Early Initiation of Macitentan for Pulmonary Arterial Hypertension
por: Jung, Hae Ok
Publicado: (2018)

Risks and benefits of vaccines in diabetes
por: Bloomgarden, Zachary
Publicado: (2023)

Prevalence, Awareness, and Control of Hypertension among Diabetic Koreans
por: Chung, Hyun Hee, et al.
Publicado: (2011)

Is There a Role for Hypolipidaemic Drug Therapy in the Prevention or Treatment of Microvascular Complications of Diabetes?
por: Mitsiou, Eydoxia K, et al.
Publicado: (2012)

Diabetic Microvascular Complications: Novel Risk Factors, Biomarkers, and Risk Prediction Models
por: McKay, Gareth J., et al.
Publicado: (2016)

The Role of Lifestyle, Eating Habits and Social Environment in the Prevention and Treatment of Type 2 Diabetes and Hypertension
por: Karatzi, Kalliopi, et al.
Publicado: (2021)

Aortic stiffness in type-1 diabetes mellitus; beware of hypertension
por: van der Wall, E. E., et al.
Publicado: (2011)

Sodium–glucose cotransporter 2 inhibitor‐associated diabetic ketoacidosis in patients with type 1 diabetes: Metabolic imbalance as an underlying mechanism
por: Ogawa, Wataru, et al.
Publicado: (2019)

Addressing self‐monitoring of blood glucose: Advocating paired glycemic testing for people with type 2 diabetes
por: Sheu, Wayne H.‐H.
Publicado: (2012)

Effects of glucose control on arterial stiffness in patients with type 2 diabetes mellitus and hypertension: An observational study
por: Chang, Sangah, et al.
Publicado: (2017)

The Association of Obesity and Microvascular Complications with Glycemic Control in Patients with Type 2 Diabetes Mellitus
por: Bijelic, Radojka, et al.
Publicado: (2020)

Pushing Boundaries: Cardiac Computed Tomography Reveals Myocardial Microvascular Dysfunction in Patients With Diabetes
por: Kitagawa, Kakuya
Publicado: (2023)

Home Blood Glucose Monitoring in Type 2 Diabetes: Broken health care system undermines study's impact
por: Hirsch, Irl B.
Publicado: (2011)

Benefits of Early Hypertension Control on Cardiovascular Outcomes in Patients With Diabetes
por: O’Connor, Patrick J., et al.
Publicado: (2013)

Optimizing glucose control for diabetic patients undergoing percutaneous coronary intervention
por: Chang, Haseong, et al.
Publicado: (2021)

Changing the diabetes treatment paradigm from glucose control to cardiorenal protection
por: Ekanayake, Preethika, et al.
Publicado: (2021)

Pleiotropic effects of rosuvastatin on microvascular function in type 2 diabetes
por: Parson, Henri K, et al.
Publicado: (2010)

Vitamin D levels and microvascular complications in type 2 diabetes
por: Bajaj, Sarita, et al.
Publicado: (2014)

Anemia and Microvascular Complications in Patients With Type 2 Diabetes Mellitus
por: Hosseini, Mahboobeh Sadat, et al.
Publicado: (2014)

Evaluate the prevalence of depression in type 2 diabetics with microvascular complications
por: Khodabandehloo, Niloofar, et al.
Publicado: (2020)

Determinants and Stratification of Microvascular Complications of Type 2 Diabetes Mellitus
por: Reddy Mallimala, Priya, et al.
Publicado: (2023)

Parathyroidectomy Ameliorates Glucose and Blood Pressure Control in a Patient with Primary Hyperparathyroidism, Type 2 Diabetes, and Hypertension
por: Kumar, Alok, et al.
Publicado: (2015)

Prandial Insulin and the Systemic Appearance of Meal-Derived Glucose in People With Type 1 Diabetes
por: Vella, Adrian, et al.
Publicado: (2008)

Hypertension and Diabetes in Obesity
por: Masuo, Kazuko, et al.
Publicado: (2011)

Time in range, as measured by continuous glucose monitor, as a predictor of microvascular complications in type 2 diabetes: a systematic review
por: Raj, Rishi, et al.
Publicado: (2022)

New Era for Renal-Protective Therapy in Type 2 Diabetes: Better Renal Outcomes in Patients with Type 2 Diabetes Taking Sodium-Glucose Cotransporter 2 Inhibitors versus Dipeptidyl Peptidase-4 Inhibitors
por: Jung, Chan-Hee
Publicado: (2021)

Hypertension and Diabetes: Entry Points for Prevention and Control of the Global Cardiovascular Epidemic
por: Mendis, Shanthi, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_domklfr5sgu3uieo3c6t7o05nu